Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Cap Fund median (29 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Invesco India Multicap Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹107.49 |
| 12 Apr 2015 | ₹192.29 |
| 31 May 2016 | ₹186.19 |
| 19 Jul 2017 | ₹246.00 |
| 07 Sep 2018 | ₹280.44 |
| 27 Oct 2019 | ₹260.54 |
| 15 Dec 2020 | ₹314.48 |
| 03 Feb 2022 | ₹462.72 |
| 25 Mar 2023 | ₹434.88 |
| 12 May 2024 | ₹665.18 |
| 01 Jul 2025 | ₹804.30 |
| 20 Aug 2026 | ₹814.20 |
| Metric | Invesco · Direct · IDCW NAV ₹145.66 Very High risk ★★★☆☆ | Category median Multi Cap Fund · 29 funds |
|---|---|---|
| +2.76% | +6.55% | |
| +15.70% | +13.71% | |
| +13.86% | +12.07% | |
| +14.74% | +9.16% | |
| +16.63% | +14.55% | |
| +13.77% | — | |
| +17.33% | +17.33% | |
| +16.51% | +14.39% | |
| +16.80% | +9.74% | |
| Risk | ||
| 15.86% | 15.40% | |
| 0.58 | 0.41 | |
| 0.80 | 0.54 | |
| -37.99% | -21.00% | |
| Nifty 500 | — | |
| +3.03% | +1.30% | |
| 1.06 | 1.03 | |
| 116.1% | 104.7% | |
| 106.7% | 99.6% | |
| 0.91% | 0.93% | |
| ₹4,057Cr | ₹4,007Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| 31% | 53% | |
| Manish Poddar · 1.1y | — | |
| 02 Jan 2013 | — | |
| 71 | — | |
| 28.2% | — | |
| 0.4% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.